Cyril Amarchand Mangaldas Advises KKR on €1.2 Billion SHCPL Acquisition

• Cyril Amarchand Mangaldas advised Medicover on the €1.2 billion agreement to sell SHCPL to KKR.
• The deal, upon its expected closing, will mark a significant milestone in India's growing healthcare sector.
• SHCPL operates 26 hospitals across four states in southern India, with Medicover holding approximately 65% of the company's shares.

The €1.2 billion agreement between Medicover and KKR, pending its expected closing, has far-reaching implications for lawyers advising clients on private equity transactions.

Cyril Amarchand Mangaldas, a leading Indian law firm, has advised Medicover on its agreement to sell its majority stake in Sahrudaya Health Care Private Ltd. (SHCPL) to global private equity giant KKR. The deal, valued at €1.2 billion, is an agreement that, upon its expected closing in the fourth quarter of 2026, will mark a significant milestone in India's growing healthcare sector. SHCPL operates 26 hospitals across four states in southern India, with Medicover holding approximately 65% of the company's shares through its subsidiary.

The agreed sale highlights the increasing interest of private equity investors in India's healthcare sector. With a growing middle class and rising demand for quality healthcare services, India presents a lucrative opportunity for investors seeking to tap into the country's burgeoning healthcare market. The deal is also notable for its size, with KKR agreeing to pay €1.2 billion for a 100% stake in SHCPL. This transaction underscores the significance of India as a destination for private equity investments, particularly in sectors like healthcare where growth prospects are high.

The €1.2 billion agreement between Medicover and KKR, pending its expected closing, has far-reaching implications for lawyers advising clients on private equity transactions. As the Indian healthcare sector continues to attract significant investment, legal professionals must be aware of the complexities involved in such deals. The transaction highlights the importance of thorough due diligence, strategic planning, and regulatory compliance in ensuring successful outcomes for investors and companies alike. Furthermore, it underscores the need for lawyers to stay abreast of emerging trends and opportunities in India's healthcare sector, where growth prospects are high.

Lawyers advising clients on private equity transactions should be aware of the implications of this €1.2 billion deal, which highlights the growing interest in India's healthcare sector and may signal new opportunities for investors.

Source: Original reporting via SCC Times